OpenAI Launches GPT-Rosalind, a Restricted Biology Model for Drug Discovery

OpenAI released GPT-Rosalind, a frontier reasoning model built specifically for biology and drug discovery — but access is limited to vetted research partners, signaling a new era of gated domain-specific AI.